Zdrowie i gospodarka · 29/05/2026

FDA Classifies Transcutaneous Electrical Nerve Stimulator for Fibromyalgia into Class II with Special Controls

The FDA has classified the transcutaneous electrical nerve stimulator to treat fibromyalgia symptoms into Class II, a category that requires special controls to ensure safety and effectiveness, aiming to enhance patients' access to innovative devices while reducing regulatory burdens.